You're reading the free version. Trader adds the live tape and alerts.
Start tracking
KYMR Sale Disclosure
Jacobs Bruce N. · SEC Form 4 · Filed Jul 2, 2026
Sale
Calculated transaction value
$923.18K
Jacobs Bruce N. Chief Financial Officer
KYMR
Kymera Therapeutics
KYMR
Transaction date
Jun 30, 2026
Public filing date
Jul 2, 2026
Filing lag
Filed 2 days later
KYMR daily price context
Close on/before transaction
$114.67
Jun 30, 2026
First close after public filing
$114.76
Jul 6, 2026
30-day return after filing
-12.59%
Through Aug 3, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Stock
- Quantity / price
- 7,971 shares @ $115.82
- SEC ownership
- Direct
- Transaction code
- S
- Form
- 4
- Filing identifier
- 0001193125-26-295090
Filing cohort
Transactions in this filing
Showing 10 of 10
Trades
10
Issuers
1
Estimated value
$9.19M
Buys / sales
0 / 8
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Kymera Therapeutics, Inc. KYMR | Exercise | Jun 30, 2026 | $327.14K |
| Kymera Therapeutics, Inc. KYMR | Sale | Jun 30, 2026 | $165.81K |
| Kymera Therapeutics, Inc. KYMR | Sale | Jun 30, 2026 | $189.66K |
| Kymera Therapeutics, Inc. KYMR | Sale | Jun 30, 2026 | $124.07K |
| Kymera Therapeutics, Inc. KYMR | Sale | Jun 30, 2026 | $469.31K |
| Kymera Therapeutics, Inc. KYMR | Sale | Jun 30, 2026 | $5.9M |
| Kymera Therapeutics, Inc. KYMR Current | Sale | Jun 30, 2026 | $923.18K |
| Kymera Therapeutics, Inc. KYMR | Sale | Jun 30, 2026 | $719.86K |
| Kymera Therapeutics, Inc. KYMR | Sale | Jun 30, 2026 | $376.65K |
| Kymera Therapeutics, Inc. KYMR | Exercise | Jun 30, 2026 | $0 |